CW September 2000

category image Volume 9
Issue Number 9
September 2000
ISSN 10593802

Oxaliplatin Improves Progression Free Survival in Colorectal Cancer Patients

Oxaliplatin, a new platinum drug, when used in combination with standard chemotherapeutic agents, as a first-line therapy, is found to prolong progression-free survival of advanced colorectal cancer patients.
Go to Previous Page
Go to Next Page

Source & Additional Reading

A. de Gramont et al., Journal of Clinical Oncology, August.

Purchase Downloadable Full-text PDF of Article: $10.00

Subscription is more cost effective than purchasing PDFs on-the-fly.  Click here for details.

Download Complete Issue CW September 2000

Purchase Downloadable Full-text PDF of Complete Issue: $20.00


Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us

Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA
phone: 518-456-0784; fax: 518-452-4955; email: info@adeninepress.com
copyright © Adeninepress, All rights reserved.




Re-initialize IP-based Login